Catalent’s expansion into China
Posted on August 19, 2013
An interview with John Chiminski and Scott Houlton
In June the BioPharma Asia team travelled to Shanghai for CPHI China 2013. During our time there I met John Chiminski, President and Chief Executive Officer, and Scott Houlton, President of Development and Clinical Services at Catalent Pharma Solutions. We were introduced by Lucy Sha, Global Strateg...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
biosimilar, Catalent, CPHI China 2013, Shangpharma, Softgel Technologies, Zhejiang Jiang Yuan Tang Biotechnology Co.
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
